94 related articles for article (PubMed ID: 29458523)
1. hnRNP G prevents inclusion on the HPV16 L1 mRNAs of the central exon between splice sites SA3358 and SD3632.
Yu H; Gong L; Wu C; Nilsson K; Li-Wang X; Schwartz S
J Gen Virol; 2018 Mar; 99(3):328-343. PubMed ID: 29458523
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
[TBL] [Abstract][Full Text] [Related]
3. HPV-16 RNA processing.
Schwartz S
Front Biosci; 2008 May; 13():5880-91. PubMed ID: 18508629
[TBL] [Abstract][Full Text] [Related]
4. Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.
Li X; Johansson C; Cardoso Palacios C; Mossberg A; Dhanjal S; Bergvall M; Schwartz S
PLoS One; 2013; 8(9):e72776. PubMed ID: 24039800
[TBL] [Abstract][Full Text] [Related]
5. Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs.
Li X; Johansson C; Glahder J; Mossberg AK; Schwartz S
Nucleic Acids Res; 2013 Dec; 41(22):10488-508. PubMed ID: 24013563
[TBL] [Abstract][Full Text] [Related]
6. hnRNP G/RBMX enhances HPV16 E2 mRNA splicing through a novel splicing enhancer and inhibits production of spliced E7 oncogene mRNAs.
Hao C; Zheng Y; Jönsson J; Cui X; Yu H; Wu C; Kajitani N; Schwartz S
Nucleic Acids Res; 2022 Apr; 50(7):3867-3891. PubMed ID: 35357488
[TBL] [Abstract][Full Text] [Related]
7. hnRNP L controls HPV16 RNA polyadenylation and splicing in an Akt kinase-dependent manner.
Kajitani N; Glahder J; Wu C; Yu H; Nilsson K; Schwartz S
Nucleic Acids Res; 2017 Sep; 45(16):9654-9678. PubMed ID: 28934469
[TBL] [Abstract][Full Text] [Related]
8. Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome.
Somberg M; Schwartz S
J Virol; 2010 Aug; 84(16):8219-30. PubMed ID: 20519389
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.
Dhanjal S; Kajitani N; Glahder J; Mossberg AK; Johansson C; Schwartz S
J Biol Chem; 2015 May; 290(21):13354-71. PubMed ID: 25878250
[TBL] [Abstract][Full Text] [Related]
10. Serine/arginine-rich protein 30c activates human papillomavirus type 16 L1 mRNA expression via a bimodal mechanism.
Somberg M; Li X; Johansson C; Orru B; Chang R; Rush M; Fay J; Ryan F; Schwartz S
J Gen Virol; 2011 Oct; 92(Pt 10):2411-2421. PubMed ID: 21697349
[TBL] [Abstract][Full Text] [Related]
11. A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein.
Zhao X; Oberg D; Rush M; Fay J; Lambkin H; Schwartz S
J Virol; 2005 Apr; 79(7):4270-88. PubMed ID: 15767428
[TBL] [Abstract][Full Text] [Related]
12. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.
Zhao X; Rush M; Schwartz S
J Virol; 2004 Oct; 78(20):10888-905. PubMed ID: 15452209
[TBL] [Abstract][Full Text] [Related]
13. The DNA damage response activates HPV16 late gene expression at the level of RNA processing.
Nilsson K; Wu C; Kajitani N; Yu H; Tsimtsirakis E; Gong L; Winquist EB; Glahder J; Ekblad L; Wennerberg J; Schwartz S
Nucleic Acids Res; 2018 Jun; 46(10):5029-5049. PubMed ID: 29596642
[TBL] [Abstract][Full Text] [Related]
14. Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632.
Somberg M; Zhao X; Fröhlich M; Evander M; Schwartz S
J Virol; 2008 Apr; 82(7):3665-78. PubMed ID: 18216120
[TBL] [Abstract][Full Text] [Related]
15. A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.
Rush M; Zhao X; Schwartz S
J Virol; 2005 Sep; 79(18):12002-15. PubMed ID: 16140776
[TBL] [Abstract][Full Text] [Related]
16. Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers.
Zhao X; Fay J; Lambkin H; Schwartz S
Virology; 2007 Dec; 369(2):351-63. PubMed ID: 17869320
[TBL] [Abstract][Full Text] [Related]
17. Identification of heterogenous nuclear ribonucleoproteins (hnRNPs) and serine- and arginine-rich (SR) proteins that induce human papillomavirus type 16 late gene expression and alter L1 mRNA splicing.
Hao C; Gong L; Cui X; Jönsson J; Zheng Y; Wu C; Kajitani N; Schwartz S
Arch Virol; 2022 Feb; 167(2):563-570. PubMed ID: 34860285
[TBL] [Abstract][Full Text] [Related]
18. A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H.
Oberg D; Fay J; Lambkin H; Schwartz S
J Virol; 2005 Jul; 79(14):9254-69. PubMed ID: 15994820
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of m6A-factors METTL3, ALKBH5, and YTHDC1 alters HPV16 mRNA splicing.
Cui X; Nilsson K; Kajitani N; Schwartz S
Virus Genes; 2022 Apr; 58(2):98-112. PubMed ID: 35190939
[TBL] [Abstract][Full Text] [Related]
20. Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs.
Wu C; Kajitani N; Schwartz S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]